Cargando…

STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in Rosiglitazone-treated mice

STAT6 interacts with PPARγ to elicit macrophage polarization towards an anti-inflammatory, insulin-sensitizing phenotype. Mice deficient in STAT6 display liver lipid accumulation (hepatosteatosis). Rosiglitazone (RSG), a PPARγ agonist, ameliorates hepatosteatosis and enhances insulin sensitivity. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sajic, Tatjana, Hainard, Alexandre, Scherl, Alexander, Wohlwend, Annelise, Negro, Francesco, Sanchez, Jean-Charles, Szanto, Ildiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734444/ https://www.ncbi.nlm.nih.gov/pubmed/23917405 http://dx.doi.org/10.1038/srep02350

Ejemplares similares

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
por: Giacalone, Giovanna, et al.
Publicado: (2018)

PKM2, STAT3 and HIF-1α: The Warburg’s vicious circle
por: Demaria, Marco, et al.
Publicado: (2012)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

PKM2 and cancer: The function of PKM2 beyond glycolysis
por: DONG, GAOCHAO, et al.
Publicado: (2016)

Lactylation of PKM2 Suppresses Inflammatory Metabolic Adaptation in Pro-inflammatory Macrophages
por: Wang, Jizhuang, et al.
Publicado: (2022)

Resistin Production from Adipose Tissue Is Decreased in db/db Obese Mice, and Is Reversed by Rosiglitazone
por: Ye, Hongying, et al.
Publicado: (2013)

Rosiglitazone Reverses Inflammation in Epididymal White Adipose Tissue in Hormone-Sensitive Lipase-Knockout Mice
por: Kotzbeck, Petra, et al.
Publicado: (2022)

PKM and the maintenance of memory
por: Glanzman, David L.
Publicado: (2013)

Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer
por: Li, Qiong, et al.
Publicado: (2015)

PKM2 is involved in neuropathic pain by regulating ERK and STAT3 activation in rat spinal cord
por: Wang, Binbin, et al.
Publicado: (2018)

Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells
por: Chen, Qiuju, et al.
Publicado: (2009)

COPI-Mediated Nuclear Translocation of EGFRvIII Promotes STAT3 Phosphorylation and PKM2 Nuclear Localization
por: Zhang, Mingzhi, et al.
Publicado: (2019)

PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation
por: Damasceno, Luis Eduardo Alves, et al.
Publicado: (2020)

2′-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice
por: Hao, Lihua, et al.
Publicado: (2021)

Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation
por: Zhang, Qiqi, et al.
Publicado: (2021)

Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011)

PKM2 in carcinogenesis and oncotherapy
por: He, Xia, et al.
Publicado: (2017)

Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte Differentiation
por: Siebert, Anna, et al.
Publicado: (2016)

No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
por: Bluemlein, Katharina, et al.
Publicado: (2011)

Chemoproteomics reveals berberine directly binds to PKM2 to inhibit the progression of colorectal cancer
por: Yan, Shi-Hai, et al.
Publicado: (2022)

Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
Publicado: (2011)

Safety and efficacy of rosiglitazone in the elderly diabetic patient
por: Viljoen, Adie, et al.
Publicado: (2009)

The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
por: Shirai, Tsuyoshi, et al.
Publicado: (2016)

Structural basis of PKM2 regulation
por: Yang, Weiwei
Publicado: (2015)

PKM2, function and expression and regulation
por: Zhang, Ze, et al.
Publicado: (2019)

The Role of PKM2 in Diabetic Microangiopathy
por: Tu, Chao, et al.
Publicado: (2022)

The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2
por: Xiao, Min, et al.
Publicado: (2020)

WZB117 enhanced the anti-tumor effect of apatinib against melanoma via blocking STAT3/PKM2 axis
por: Zhang, Ren-Shu, et al.
Publicado: (2022)

Rosiglitazone-Induced Mitochondrial Biogenesis in White Adipose Tissue Is Independent of Peroxisome Proliferator-Activated Receptor γ Coactivator-1α
por: Pardo, Rosario, et al.
Publicado: (2011)

Simpson's paradox visualized: The example of the Rosiglitazone meta-analysis
por: Rücker, Gerta, et al.
Publicado: (2008)

A phase II trial with rosiglitazone in liposarcoma patients
por: Debrock, G, et al.
Publicado: (2003)

Rosiglitazone as an option for patients with acromegaly: a case series
por: Tamez-Pérez, Héctor E, et al.
Publicado: (2011)

In vivo effects of rosiglitazone in a human neuroblastoma xenograft
por: Cellai, I, et al.
Publicado: (2010)

Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2009)

Rosiglitazone activation of PPARγ suppresses fractalkine signaling
por: Wan, Yihong, et al.
Publicado: (2010)

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?
por: Rahman, Sayeeda, et al.
Publicado: (2009)

Interactions of Rosiglitazone and Anti-Arrhythmic Drugs in Animal Model
por: Mohammed, YM, et al.
Publicado: (2012)

Topical Rosiglitazone Is an Effective Anti-Scarring Agent in the Cornea
por: Huxlin, Krystel R., et al.
Publicado: (2013)

Effects of rosiglitazone on contralateral iliac artery after vascular injury in hypercholesterolemic rabbits
por: França Neto, Olímpio Ribeiro, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_eq5vbknqh92up7dni0pkuqcmj2